Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Q & M Dental Group (Singapore) Limited ( (SG:QC7) ) just unveiled an announcement.
Q & M Dental Group (Singapore) Limited announced that its associated company, EM2AI Pte. Ltd., has received medical device licenses in Thailand, Philippines, Vietnam, and Indonesia for its dental AI solutions. This development enables EM2AI to expand its sales and distribution network across these new markets, actively seeking distributors and customers, thereby enhancing its business growth and the company’s regional market positioning.
More about Q & M Dental Group (Singapore) Limited
Q & M Dental Group (Singapore) Limited operates in the healthcare industry, focusing on dental services. The company provides dental care solutions and has expanded its market presence through technological innovations, such as dental artificial intelligence solutions via its associated company, EM2AI Pte. Ltd.
YTD Price Performance: 1.00%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €190.5M
Find detailed analytics on QC7 stock on TipRanks’ Stock Analysis page.